Thomas Horn

Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens

Jeremy D. Waight, Dhan Chand, Sylvia Dietrich et al. · Cancer Cell · 2018 · 99 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models

Sunkyu Kim, Ralph Tiedt, Alice Loo et al. · Oncotarget · 2018 · 93 citations · Full text

Medicine, Oncology, Pharmacology +14

Frequencies and Prognostic Role of KRAS and BRAF Mutations in Patients With Localized Pancreatic and Ampullary Adenocarcinomas

Nicolai Aagaard Schultz, Anne Roslind, Ib Jarle Christensen et al. · Pancreas · 2012 · 67 citations

Medicine, Molecular Genetics, Oncology +16

Synthetic biology-based cellular biomedical tattoo for detection of hypercalcemia associated with cancer

Aizhan Tastanova, Marc Folcher, Marius Müller et al. · Science Translational Medicine · 2018 · 55 citations · Full text

Life Sciences, Biotechnology, Oncology +17

Overexpression of Cyclooxygenase-2 in Rat Oral Cancers and Prevention of Oral Carcinogenesis in Rats by Selective and Nonselective COX Inhibitors

David L. McCormick, Jonathan Phillips, Thomas Horn et al. · Cancer Prevention Research · 2010 · 50 citations · Full text

Medicine, Oncology, Pharmacology +12